Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
-
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
-
Expedia Group Reports Third Quarter 2025 Results
-
Matisse Capital Files Application for ETF Share Class Exemptive Relief
-
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
-
AKAMAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
-
Ross Stores, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call
-
Wynn Resorts, Limited Reports Third Quarter 2025 Results
-
Doximity Announces Fiscal 2026 Second Quarter Financial Results
-
MindMed Reports Q3 2025 Financial Results and Business Updates
-
BILL Reports First Quarter Fiscal Year 2026 Financial Results
-
VTEX Reports Third Quarter 2025 Financial Results
-
The Trade Desk Reports Third Quarter 2025 Financial Results
-
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
-
Progyny, Inc. Announces Third Quarter 2025 Results
-
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
-
Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights
-
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
Peloton Announces Q1 2026 Financial Results, Raises Full Year 2026 Adjusted EBITDA Guidance
-
Delcath Systems to Participate in Upcoming Investor Conferences
-
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
-
Teknova Reports Third Quarter 2025 Financial Results
-
Sunrun Reports Third Quarter 2025 Financial Results
-
Astec Industries, Inc. (NASDAQ: ASTE) to Participate in Baird 2025 Global Industrial Conference on November 13, 2025
-
USA Rare Earth Reports Third Quarter 2025 Financial Results
-
Turtle Beach Corporation Announces Third Quarter 2025 Financial Results and Reiterates Full Year Guidance
-
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
-
GigaCloud Technology Inc Announces Third Quarter and Nine Months Ended September 30, 2025 Financial Results
-
Research Frontiers Reports Third Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today
-
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2025
-
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
-
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
-
Mighty Wheels® Rolls Into Chicago Toy & Games Fair Showcasing Its 16-Inch Steel Trucks, Firetruck and Mighty Man Cartoon Series
-
Travertine selected by Arianne for partnership on next-gen phosphate technology
-
Global Health Forum Unveils Next Chapter in Global Collaboration and Innovation at Landmark Congress in New York
-
Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates
-
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Bimini Capital Management Announces Third Quarter 2025 Results
-
Blend Announces Third Quarter 2025 Financial Results
-
IPG Photonics Expands Operations to Huntsville Alabama, Bringing Innovation to the Defense Industry
-
Half of Anywhere Real Estate agents say they would consider leaving if Compass acquisition moves forward
-
Curis Provides Third Quarter 2025 Business Update
-
Alkermes to Participate in Two Upcoming Investor Conferences
-
Expensify Announces Q3 2025 Results
-
WF International Announces Closing of $3.44 Million Follow-on Public Offering
-
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

